Denali Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.About DNLI
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.
DNLI Key Statistics
Stock Snapshot
Denali Therapeutics(DNLI) stock is priced at $19.70, giving the company a market capitalization of 2.93B. It carries a P/E multiple of -6.86.
As of 2025-12-06, Denali Therapeutics(DNLI) stock has fluctuated between $19.70 and $20.61. The current price stands at $19.70, placing the stock 0.0% above today's low and -4.4% off the high.
Denali Therapeutics(DNLI) shares are trading with a volume of 2.02M, against a daily average of 1.55M.
During the past year, Denali Therapeutics(DNLI) stock moved between $10.57 at its lowest and $26.18 at its peak.
During the past year, Denali Therapeutics(DNLI) stock moved between $10.57 at its lowest and $26.18 at its peak.
DNLI News
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
Denali Therapeutics (DNLI) and Royalty Pharma (RPRX) announced a $275 million synthetic royalty funding agreement based on future net sales of tividenofusp alfa...